What is the CVSS score of CVE-2023-40150?

CVE-2023-40150 has a CVSS 3.1 base score of 9.8 (Critical). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H. EPSS exploitation probability: 1.0%.

Meddream Pacs CVE-2023-40150

CRITICAL

Exposed Dangerous Method or Function (CWE-749)

2023-09-11 ics-cert@hq.dhs.gov

RCE Meddream Pacs

9.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

9.8 CRITICAL

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Sep 11, 2023 - 20:15 nvd

CRITICAL 9.8

DescriptionNVD

Softneta MedDream PACS does not perform an authentication check and performs some dangerous functionality, which could result in unauthenticated remote code execution.0

AnalysisAI

Softneta MedDream PACS does not perform an authentication check and performs some dangerous functionality, which could result in unauthenticated remote code execution.0. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-749. Softneta MedDream PACS does not perform an authentication check and performs some dangerous functionality, which could result in unauthenticated remote code execution.0 Affected products include: Softneta Meddream Pacs.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.